Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics.
about
Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Resistance to receptor-blockin ...... for HER3-homing nanobiologics.
@en
Resistance to receptor-blockin ...... for HER3-homing nanobiologics.
@nl
type
label
Resistance to receptor-blockin ...... for HER3-homing nanobiologics.
@en
Resistance to receptor-blockin ...... for HER3-homing nanobiologics.
@nl
prefLabel
Resistance to receptor-blockin ...... for HER3-homing nanobiologics.
@en
Resistance to receptor-blockin ...... for HER3-homing nanobiologics.
@nl
P2093
P2860
P1476
Resistance to receptor-blockin ...... for HER3-homing nanobiologics.
@en
P2093
Alice Chung
Altan Rentsendorj
Anjali Jain
Armando Giuliano
Beth Y Karlan
Bingchen Han
Dustin Srinivas
Felix Alonso-Valenteen
Hasmik Agadjanian
P2860
P304
P356
10.1016/J.JCONREL.2017.12.024
P407
P577
2017-12-27T00:00:00Z